Step Pharma

French tech company | Builders Republic

About

Clinical-stage biotech developing a first-in-class oral cancer drug, dencatistat, that blocks an enzyme tumors and immune cells need to multiply — in human trials for T- and B-cell lymphomas and solid tumors, pursuing a single-molecule, multiple-indication pipeline strategy.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Series C
Founded
2014
City
PARIS
Region
Auvergne-Rhône-Alpes
Tracked rounds
1
Amount raised
38 M€ raised since 2020

Recognition

  • French Tech 120

Funding rounds

  • Series C — 2025

Investors